inteliquet, an IQVIA business

Leading provider of oncology solutions and insights, transforming the accessibility and usability of cancer clinical research and real-world evidence.

[inteliquet, an IQVIA business @inteliquet]

Spending too much time on feasibility survey questionnaires (FSQs)? A #cancer center in the Southwest went from spending 24-48 hours a week on the process to 30 minutes a week with Inteliquet™.
Learn how.👉: https://t.co/bGeduHU2JV
#patientmatching #clinicaltrials

[inteliquet, an IQVIA business @inteliquet]

We appreciate everyone who stopped by to discuss #diversity and locational disparities. We want to even the playing field for minority groups and those in rural, underrepresented regions. Continue the conversation at https://t.co/Mb0KLFNZET. @MySCRS

[inteliquet, an IQVIA business @inteliquet]

Join us at @MySCRS’s Global Oncology Site Solutions Summit! Inteliquet is at Booth #23, discussing equitable, accessible cancer center support and patient enrollment services. Visit us at https://t.co/sFxEHvuiXV to learn more. #cancerresearch

[inteliquet, an IQVIA business @inteliquet]

So few oncology patients are leveraging clinical trials as a form of possible treatment—even fewer are from minority populations. Stop by Booth #23 to discuss #diversity in oncology trials. Visit https://t.co/3H0r6ZOKve for more information. @MySCRS

[inteliquet, an IQVIA business @inteliquet]

Join Inteliquet and @MySCRS at Booth #23 from May 21-22 for the 2022 Global Oncology Site Solutions Summit. Join us to discuss how to improve equitable #oncology clinical trial accessibility. Learn more: https://t.co/Hr62KgaO6f

[inteliquet, an IQVIA business @inteliquet]

Join us for the @MySCRS site-focused #diversity conference in the clinical trial industry, aiming to help sites recruit and retain more diverse patient populations. Join our discussion around equitability in #clinicaltrials: https://t.co/RjAvYZBhXk

[inteliquet, an IQVIA business @inteliquet]

Thank you to Inteliquet’s Jeanie Gatewood for representing the team and sharing invaluable insight, as usual. Until next time, #MAGIworld! We’re making strides in cancer research. Learn more 👉 https://t.co/nOpttSqiuh

[inteliquet, an IQVIA business @inteliquet]

Inteliquet’s Jeanie Gatewood is participating in a panel focused on empowering cancer research programs via data analytics on Sunday, May 1, from 2:45-5:45 PM (G858). Join online or in person: https://t.co/iCBxmQTTwQ

[inteliquet, an IQVIA business @inteliquet]

A study by the Robert Wood Johnson Foundation found that Black and Hispanic adults are very unlikely to have a provider of the same race. Read why:
https://t.co/njjAjkzp36 #DataOps #ClinicalTrial #DiversityinHealthcare

[inteliquet, an IQVIA business @inteliquet]

Thank you for exploring clinical trial process improvements and new practices impacting Site efficiency such as biomarker parsing and decentralized trials at #ACRP2022. Learn more about our capabilities in #cancerresearch at https://t.co/X7Q349IFNO.

[inteliquet, an IQVIA business @inteliquet]

Like many clinical trials, minority groups are underrepresented in prostate cancer clinical trial studies. Read more about it in Healthline's latest piece:

https://t.co/B0dHIhyjY9 #DataOps #ProstateCancer #CancerTreatment #ClinicalTrials

[inteliquet, an IQVIA business @inteliquet]

Join Inteliquet for a special presentation, “How Digital Technology is Transforming Clinical Trials – And What This Means for Site Operations” [Date, Time] Learn more at https://t.co/jfRCxR5SGa. @ACRPDC

[inteliquet, an IQVIA business @inteliquet]

At Inteliquet, we strive to be connectors to bring more clinical research to cancer centers. Learn how in Pharma's Almanac's latest piece with Inteliquet:
https://t.co/U1Llm5flFL #ClinicalTrails #Leadership #HealthcareLeadership

[inteliquet, an IQVIA business @inteliquet]

There has been immense pressure on healthcare managers due to the Great Resignation and the ongoing pandemic. Read Becker’s latest piece to learn more:

https://t.co/XOqRHJPw9J #DataOps #HealthcareLeadership #Healthcare #PatientMatching

[inteliquet, an IQVIA business @inteliquet]

With clinical trials held back at the beginning of the pandemic, helping more cancer centers re-engage in clinical research is more important than ever. Learn more in Pharma's Almanac's latest piece with Inteliquet:
https://t.co/9bL9aTiAha #CancerResearch #ClinicalTrials

[inteliquet, an IQVIA business @inteliquet]

Learn how clinical trials as a treatment option build on best practices for Site process improvements impact efficiency, revenue cycle management, and transform the patient enrollment journey. https://t.co/Jkte5PX4jP @ACRPDC

[inteliquet, an IQVIA business @inteliquet]

We’re hiring! Help drive healthcare forward & learn about our positions:
Product Manager: https://t.co/JetAffcowW
Associate Director: https://t.co/tmVuZes4hi
Associate Director: https://t.co/ek2C44IKz7
Inteliquet Business Development/ Sales Director: https://t.co/DtiK0r4FVU

[inteliquet, an IQVIA business @inteliquet]

A recent article, in Becker's Healthcare, explores how CSuite networks can break out of COVID crisis-mode. Read more to learn how.

https://t.co/i5vvLWlaok #DatOps #PatientMatching #COVID #HospitalSystems

[inteliquet, an IQVIA business @inteliquet]

Restricting eligibility can prevent participation from patients who could potentially benefit from clinical trials. Read the @Nature's recent study to learn why.

https://t.co/86MIxNLYEp #ClinicalTrials #PatientMatching #TrialEligability #DataOps

[inteliquet, an IQVIA business @inteliquet]

Congratulations, @WBLFoundation, for a successful event! 👏 We look forward to being a part of the open conversations that lead to change in healthcare. Together, we can make an impact on patients everywhere. See what we’re up to: https://t.co/ovZ5xi0VkB

[inteliquet, an IQVIA business @inteliquet]

Look for Marie Lamont at the 2022 WBL Summit! 👩‍⚕️👩‍💼 She leads the Inteliquet team in pursuit of a new, innovative approach to cancer clinical trials and research. Learn more: https://t.co/1BIfz8Pk9A #ClinicalResearch